Work

Promising results Halt phase III studies of idelalisib.

Year: 2014

Type: article

Source: PubMed

Author: Silas Inman

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W22109903

FWCI:

Cites: 39

Cited by:

Related to: 10